8 Nov 2010 14:21

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES | ||||||||||||||||
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: | ARK THERAPEUTICS GROUP PLC | |||||||||||||||
2 Reason for the notification (please tick the appropriate box or boxes): | ||||||||||||||||
 An acquisition or disposal of voting rights | x | |||||||||||||||
 An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached | ||||||||||||||||
 An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments | ||||||||||||||||
 An event changing the breakdown of voting rights | ||||||||||||||||
 Other (please specify): |
| |||||||||||||||
3. Full name of person(s) subject to the notification obligation: Â | Â Gartmore Investment Limited | |||||||||||||||
4. Full name of shareholder(s) (if different from 3.):  | Registered Owner: BNY GIL CLT Account Nominees Ltd  Beneficial Owner: Gartmore Fledgling Trust PLC | |||||||||||||||
5. Date of the transaction and date on which the threshold is crossed or reached: Â | Â 3 November 2010 | |||||||||||||||
6. Date on which issuer notified: Â | Â 5 November 2010 | |||||||||||||||
7. Threshold(s) that is/are crossed or reached: Â | Â 5% | |||||||||||||||
8. Notified details: | ||||||||||||||||
A: Voting rights attached to shares  | ||||||||||||||||
Class/type ofshares if possible usingthe ISIN CODE | Situation previousto the triggeringtransaction | Resulting situation after the triggering transaction | ||||||||||||||
NumberofShares | NumberofVotingRights | Numberof shares | Number of votingrights | % of voting rights | ||||||||||||
Direct | Direct | Indirect | Direct | Indirect | ||||||||||||
 Ordinary GB0034251727 |  9,810,000 | 9,810,000 | 10,810,000 | 10,810,000 | 5.166% | |||||||||||
B: Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction  | ||||||||||||||||
Type of financialinstrument | Expirationdate | Exercise/ConversionPeriod | Number of votingrights that may beacquired if theinstrument isexercised/ converted. Â | % of votingrights | ||||||||||||
 N/A | ||||||||||||||||
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments | ||||||||||||||||
Resulting situation after the triggering transaction  | ||||||||||||||||
Type of financialinstrument | Exerciseprice | Expirationdate | Exercise/Conversionperiod | Number of votingrights instrumentrefers to | % of voting rights  | |||||||||||
 N/A | Nominal | Delta  | ||||||||||||||
Total (A+B+C) Â | ||||||||||||||||
Number of voting rights | Percentage of voting rights | |||||||||||||||
 10,810,000 | 5.166% | |||||||||||||||
9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: | ||||||||||||||||
Proxy Voting: Â | ||||||||||||||||
10. Name of the proxy holder: Â | ||||||||||||||||
11. Number of voting rights proxy holder will cease to hold: Â | ||||||||||||||||
12. Date on which proxy holder will cease to hold voting rights: Â | ||||||||||||||||
13. Additional information: Â | Â Email contact: RDU@gartmore.com | |||||||||||||||
14. Contact name: Â | Â RDU | |||||||||||||||
15. Contact telephone number: Â | Â 0207 782 2324 | |||||||||||||||
Â